Nomura Holdings Inc Legend Biotech Corp Transaction History

Nomura Holdings Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $201,354 - $255,953	3,657 New	3,657 $205,000
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $1.11 Million - $1.46 Million	-25,457 Reduced 78.54%	6,955 $335,000
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $1.26 Million - $1.8 Million	32,412 New	32,412 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $132,717 - $217,635	3,957 New	3,957 $215,000
Q1 2022 May 18, 2022	SELL	$31.02 - $48.18 $4.22 Million - $6.56 Million	-136,132 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $226,270 - $313,390	5,500 Added 4.21%	136,132 $6.35 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $3.37 Million - $5.37 Million	130,632 New	130,632 $5.33 Million
Q1 2021 May 17, 2021	SELL	$23.55 - $32.4 $3.08 Million - $4.23 Million	-130,632 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $1,161 - $1,457	-45 Reduced 0.03%	130,632 $3.85 Million
Q3 2020 Nov 12, 2020	BUY	$27.5 - $39.61 $3.59 Million - $5.18 Million	130,677 New	130,677 $4.04 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.85B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.